blog

print rss Bookmark and Share

Cancer Care Centers seek ePedigree counterfeiting protection

Written By: Brian Daleiden

Sunday, November 22, 2009

Interesting little article popped up today by San Antonio TV station KENS 5 that discussed how the Cancer Care Centers of South Texas are using E-Pedigree for drug counterfeiting protection. CCS uses an ePedigree-based online tracking system to help caregivers validate the authenticity of pharmaceuticals prior to their delivery or dispensation to patients. The ePedigree system helps create a secure chain of custody as a drug moves along the supply chain while providing a quick snapshot of this chain of custody at any time via a browser-based portal available at point of dispensation. For cancer drugs, providing traceability through this kind of anti-counterfeit barrier has been particularly important to establish as the high value and demand of these pharmaceuticals make them noted targets for counterfeiters.

Unlike many stories of these types, it was the human element of this story that caught my eye. Often, the human side of the equation gets lost when talking about anti-counterfeiting technologies and supply chain traceability initiatives. The bits, bytes, system integration and other business issues typically come to the foreground instead. Perhaps this is understandable given everyone has a business to run and drug track and trace systems can be likened to an insurance policy against counterfeiting, diversion, theft, etc. Thus, a poignant comment made by an oncologist in the story tended to stand out to me: “It’s very important for patients to feel that where they are getting treated, they’re actually getting what’s prescribed for them because it’s a matter of life and death,” explained oncologist Dr. Anu Dham. “It’s cancer treatment.”

I also have more than a casual interest in a story like this as CCS is affiliated with US Oncology, a leading cancer treatment and research network. US Oncology has been a long standing customer of TraceLink / SupplyScape and we have worked closely with USO to assist them in building out their portal-based online drug tracking system. I haven't had the opportunity to visit one of USO's clinics in the past like several of my colleagues here have. So, little stories like these are particularly nice when they give you a little snapshot of those fighting the good fight "from the field".